{"transactions":[{"id":2340095,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":129267,"kind":"person","name":"Skalicky Gregory","position":1,"cik":"0001878571","reported_name":"Skalicky Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B common stock","published_at":"2022-03-10T17:30:35.000Z","date":"2022-01-06","kind":"other","acquired":false,"shares":953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"kind","element":"transactionCoding","label":"F2","text":"As contemplated in connection with the initial public offering of the Issuer, 953 shares of Class B common stock of the Issuer were forfeited for no consideration and cancelled because the underwriters of the Issuer's initial public offering did not exercise their over-allotment option in full, as described in the Issuer's Registration Statement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the Issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the Issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"}],"balance_after":8631,"derivative":{"underlying":"Class A common stock","underlying_shares":953},"source":{"system":"sec-edgar","filing":"0001213900-22-011642","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878571/000121390022011642/ownership.xml","form_type":"4"}}]}